´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day3 : 2023-07-08
±³À°ÀÏÀÚ : 2023-07-08
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 ¿Ü 1°³·ë
±³À°ÁÖÁ¦ : APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day3
ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : Ȳ¼öÁ¤
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ : apple2023@hbni.co.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í [Regular Registration-Non-Member Rate] Doctor, Healthcare Professionals: KRW 300,000 / USD 300 Fellow, Resident, Researcher, Others: KRW 250,000 / USD 250 Poster Presenter: KRW 100,000 / USD 100 [Regular Registration-Member Rate] Doctor, Healthcare Professionals: KRW 250,000 / USD 250 Fellow, Resident, Researcher, Others: KRW 200,000 / USD 200 Poster Presenter: KRW 100,000 / USD 100
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 08:30~08:50 Optimal First-Line Therapy for HCC Baek-Yeol Ryoo(Univ. of Ulsan)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 08:50~09:10 Optimal Subsequent Option after First-Line Immuno-Oncology Therapy Andrew Zhu(I-Mab Biopharma, Shanghai)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 09:10~09:30 Optimal Subsequent Option after First-Line Tyrosine Kinase Inhibitor Therapy Chih-Hung Hsu(National Taiwan Univ., Taipei)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 09:30~09:50 Matching the Right Agents with the Right Patients for the Management of HCC: Biomarkers for Systemic Therapy Thomas Yau(The Univ. of Hong Kong, Hong Kong)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 09:50~10:00 Discussion Baek-Yeol Ryoo, Andrew Zhu, Chih-Hung Hsu, Thomas Yau(Univ. of Ulsan, I-Mab Biopharma, Shanghai, National Taiwan Univ., Taipei, The Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 10:20~11:00 Update on the Molecular-Pathological Features of HCC and Cholangiocarcinoma Young Nyun Park(Yonsei Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 11:00~11:20 Trajectory of Immune Evolution and Mechanism of Response to Immunotherapy in Hepatocellular Carcinoma Valeri Chew (Duke-NUS Medical School, Singapore)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 11:20~11:40 Rechallenging of Immuno-Oncology Treatment after Complications: Can It Be Done Safely? Stephen Lam Chan(The Chinese Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 11:40~12:00 Neo-Adjuvant or Adjuvant Immunotherapy in HCC: Where Are We Now? Ann-Lii Cheng(National Taiwan Univ. Taipei)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 12:00~12:20 Immuno-Oncology in the Treatment of HCC: Future Perspectives Richard Finn(Univ. of California Los Angeles, LA)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 12:20~12:30 Discussion Valeri Chew, Stephen Lam Chan, Ann-Lii Cheng, Richard Finn(Duke-NUS Medical School, Singapore, The Chinese Univ. of Hong Kong, Hong Kong, National Taiwan Univ. Taipei, Univ. of California Los Angeles, LA)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 13:30~13:50 Novel Targets in HCC Augusto Villanueva(Icahn School of Medicine at Mount Sinai, New York)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 13:50~14:10 CAR T Cell Therapy in HCC: Prospects and Challenges Kyungho Choi(Seoul National Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 14:10~14:30 Promising Agents in Early Clinical Trials for Liver Cancer Masafumi Ikeda(National Cancer Center Hospital East, Kashiwa)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 14:30~14:50 Radiation Therapy in HCC: Future Perspectives Jinsil Seong(Yonsei Univ.)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 14:50~15:00 Discussion Augusto Villanueva, Kyungho Choi, Masafumi Ikeda, Jinsil Seong(Icahn School of Medicine at Mount Sinai, New York, Seoul National Univ., National Cancer Center Hospital East, Kashiwa, Yonsei Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 15:20~15:40 Pathological and Molecular Features of Intrahepatic Cholangiocarcinoma Peter Schirmacher(Universität Heidelberg, Heidelberg)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 15:40~16:00 Surgical Management of Intrahepatic Cholangiocarcinoma: Comparison with HCC Etsuro Hatano(Kyoto Univ., Kyoto)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 16:00~16:20 Systemic Therapy for Intrahepatic Cholangiocarcinoma: Current and Future Perspectives Do-Youn Oh(Seoul National Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 16:20~16:40 Radiation Therapy for Intrahepatic Cholangiocarcinoma Christopher Crane(Weill Cornell College at Cornell Univ., New York)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 1 16:40~16:50 Discussion Peter Schirmacher, Etsuro Hatano, Do-Youn Oh, Christopher Crane(Universität Heidelberg, Heidelberg, Kyoto Univ., Kyoto, Seoul National Univ., Weill Cornell College at Cornell Univ., New York)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 08:30~08:50 AI-Based Cancer Screening Using Liquid Biopsy Eun-Hae Cho(GC Genome)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 08:50~09:10 Qualitative and Quantitative Imaging Biomarkers to Predict Prognosis of HCC Seung Soo Lee (Univ. of Ulsan)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 09:10~09:30 AI based pathology: a new generation of biomarkers for hepatocellular carcinoma Julien Calderaro(Université Paris-Est Créteil, Créteil)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 09:30~09:50 Predicting HCC Risk Using Artificial Intelligence Jeong-Hoon Lee(Seoul National Univ.)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 09:50~10:00 Discussion Eun-Hae Cho, Seung Soo Lee, Julien Calderaro, Jeong-Hoon Lee(GC Genome, Univ. of Ulsan, Université Paris-Est Créteil, Créteil, Seoul National Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 10:20~11:00 Update on the Molecular-Pathological Features of HCC and Cholangiocarcinoma Young Nyun Park(Yonsei Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 11:00~11:20 Extended Criteria for Liver Transplantation in HCC Toru Ikegami(Kyushu Univ., Fukuoka)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 11:20~11:40 Down-Staging and Waiting Times for Liver Transplantation in Advanced HCC Dong Jin Joo(Yonsei Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 11:40~12:00 Role of Transplantation in Combined Hepatocellular-Cholangiocarcinoma Linda Wong(Univ. of Hawaii, Honolulu)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 12:00~12:20 Multidisciplinary Approach for Post-Liver Transplantation Recurrence Kenneth Siu Ho Chok(The Univ. of Hong Kong, Hong Kong)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 12:20~12:30 Discussion Toru Ikegami, Dong Jin Joo, Linda Wong, Kenneth Siu Ho Chok(Kyushu Univ., Fukuoka, Yonsei Univ., Univ. of Hawaii, Honolulu, The Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 13:30~13:50 Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Unresectable HCC Jian Zhou(Fudan Univ., Shanghai)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 13:50~14:10 Liver Resection for Multiple HCC Shin Hwang(Univ. of Ulsan)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 14:10~14:30 Surgical Resection for Intrahepatic and Extrahepatic Recurrent HCC Etsuro Hatano(Kyoto Univ., Kyoto)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 14:30~14:50 Laparoscopic Repeated Liver Resection for Recurrent HCC Zenichi Morise(Fujita Health Univ., Toyoake)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 14:50~15:00 Discussion Jian Zhou, Shin Hwang, Etsuro Hatano, Zenichi Morise(Fudan Univ., Shanghai, Univ. of Ulsan, Kyoto Univ., Kyoto, Fujita Health Univ., Toyoake)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 15:20~15:40 Morphological Classification of HCC and Potential Clinical Implications Haeryoung Kim(Seoul National Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 15:40~16:00 Stratification of HCC : Cellular, Molecular and Blood-Based Biomarkers Irene Ng(The Univ. of Hong Kong, Hong Kong)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 16:00~16:20 Correlation of Imaging and Molecular-Pathologic Subtypes of HCC Jin-Young Choi(Yonsei Univ.)
±³À°½Ã°£ 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 16:20~16:40 Biopsy for HCC: Tissue or Liquid? Xin-Rong Yang(Fudan Univ, Shanghai)
Åä·Ð 07¿ù 08ÀÏ ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 5F Room 2 16:40~16:50 Discussion Haeryoung Kim, Irene Ng, Jin-Young Choi, Xin-Rong Yang(Seoul National Univ., The Univ. of Hong Kong, Hong Kong, Yonsei Univ., Fudan Univ, Shanghai)